The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
- PMID: 8147960
- DOI: 10.1056/NEJM199307293290502
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
Abstract
Background: A cause-and-effect relation between blood glucose concentrations and microvascular complications in patients with insulin-dependent diabetes mellitus has not been established.
Methods: We randomly assigned 102 patients with insulin-dependent diabetes mellitus, nonproliferative retinopathy, normal serum creatinine concentrations, and unsatisfactory blood glucose control to intensified insulin treatment (48 patients) or standard insulin treatment (54 patients). We then evaluated them for microvascular complications after 18 months and 3, 5, and 7.5 years.
Results: Mean (+/- SD) glycosylated hemoglobin values were reduced from 9.5 +/- 1.3 percent to 7.1 +/- 0.7 percent in the group receiving intensified treatment and from 9.4 +/- 1.4 percent to 8.5 +/- 0.7 percent in the group receiving standard treatment (P = 0.001). In 12 of the patients receiving intensified treatment (27 percent of those included in the analysis) and 27 of those receiving standard treatment (52 percent), serious retinopathy requiring photocoagulation developed (P = 0.01). Visual acuity decreased in 6 patients receiving intensified treatment (14 percent) and in 18 receiving standard treatment (35 percent) (P = 0.02). Nephropathy (urinary albumin excretion, > 200 micrograms per minute) developed in one patient in the group receiving intensified treatment, as compared with nine patients in the group receiving standard treatment (P = 0.01). No patient in the intensified-treatment group had nephropathy with subnormal glomerular filtration rates, as compared with six patients in the standard-treatment group (P = 0.02). The conduction velocities of the ulnar, tibial, peroneal, and sural nerves decreased significantly more in the standard-treatment group than in the intensified-treatment group. The odds ratio for serious retinopathy was 0.4 (95 percent confidence interval, 0.2 to 1.0; P = 0.04) in the intensified-treatment group as compared with the standard-treatment group. The corresponding odds ratio for nephropathy was 0.1 (95 percent confidence interval, 0 to 0.8; P = 0.04).
Conclusions: Long-term intensified insulin treatment, as compared with standard treatment, retards the development of microvascular complications in patients with insulin-dependent diabetes mellitus.
Comment in
- ACP J Club. 1994 Mar-Apr;120 Suppl 2:30-1
Similar articles
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401. N Engl J Med. 1993. PMID: 8366922 Clinical Trial.
-
Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years.J Intern Med. 1991 Aug;230(2):101-8. doi: 10.1111/j.1365-2796.1991.tb00415.x. J Intern Med. 1991. PMID: 1865159 Clinical Trial.
-
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.Diabetes Res Clin Pract. 1995 May;28(2):103-17. doi: 10.1016/0168-8227(95)01064-k. Diabetes Res Clin Pract. 1995. PMID: 7587918 Clinical Trial.
-
[The study of development and progression of long-term complications in type I diabetes].Nihon Rinsho. 2002 Sep;60 Suppl 9:134-9. Nihon Rinsho. 2002. PMID: 12386984 Review. Japanese. No abstract available.
-
Microvascular complications of diabetes.Endocrinol Metab Clin North Am. 2004 Mar;33(1):215-38, xi-xii. doi: 10.1016/j.ecl.2003.12.003. Endocrinol Metab Clin North Am. 2004. PMID: 15053904 Review. No abstract available.
Cited by
-
Could Online Education Replace Face-to-Face Education in Diabetes? A Systematic Review.Diabetes Ther. 2024 Jul;15(7):1513-1524. doi: 10.1007/s13300-024-01595-6. Epub 2024 May 14. Diabetes Ther. 2024. PMID: 38743305 Free PMC article. Review.
-
The Glucose Management Indicator: Time to Change Course?Diabetes Care. 2024 Jun 1;47(6):906-914. doi: 10.2337/dci23-0086. Diabetes Care. 2024. PMID: 38295402 Review.
-
Long-term quality-of-care score for predicting the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus.World J Diabetes. 2023 Jul 15;14(7):1091-1102. doi: 10.4239/wjd.v14.i7.1091. World J Diabetes. 2023. PMID: 37547581 Free PMC article.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
-
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes.Pediatr Diabetes. 2022 Dec;23(8):1270-1276. doi: 10.1111/pedi.13455. Pediatr Diabetes. 2022. PMID: 36537523 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical